10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 250 filers reported holding 10X GENOMICS INC in Q2 2022. The put-call ratio across all filers is 0.59 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $56,546,000 | -70.5% | 1,249,646 | -50.4% | 4.82% | -58.6% |
| Q1 2022 | $191,582,000 | -35.8% | 2,518,500 | +25.7% | 11.65% | -12.1% |
| Q4 2021 | $298,516,000 | +6.7% | 2,004,000 | +4.3% | 13.24% | +3.8% |
| Q3 2021 | $279,805,000 | -25.7% | 1,922,000 | 0.0% | 12.76% | -19.1% |
| Q2 2021 | $376,366,000 | +8.2% | 1,922,000 | 0.0% | 15.78% | -4.8% |
| Q1 2021 | $347,882,000 | +27.8% | 1,922,000 | 0.0% | 16.58% | +41.8% |
| Q4 2020 | $272,155,000 | +13.6% | 1,922,000 | 0.0% | 11.69% | +0.3% |
| Q3 2020 | $239,635,000 | +87.0% | 1,922,000 | +33.9% | 11.66% | +76.1% |
| Q2 2020 | $128,160,000 | – | 1,435,000 | – | 6.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $174,178,000 | 96.89% |
| Foresite Capital Management II, LLC | 2,253,528 | $407,889,000 | 93.76% |
| Foresite Capital Management I, LLC | 1,000,000 | $181,000,000 | 91.29% |
| 12 West Capital Management LP | 1,922,000 | $347,882,000 | 16.58% |
| FINANCIAL CONSULATE, INC | 158,758 | $28,735,000 | 11.65% |
| Meritech Capital Associates V L.L.C. | 2,123,356 | $384,327,000 | 9.48% |
| Andar Capital Management HK Ltd | 48,000 | $8,688,000 | 9.16% |
| JS Capital Management LLC | 517,256 | $93,623,000 | 4.84% |
| Ground Swell Capital, LLC | 3,713 | $672,000 | 2.17% |
| Renaissance Capital LLC | 79,518 | $14,393,000 | 2.13% |